Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Case Report
Plasma Concentrations of Cytokines and Neurohumoral Factors in a Case of Fulminant Myocarditis Successfully Treated With Intravenous Immunoglobulin and Percutaneous Cardiopulmonary Support
Satoru AbeYuji OkuraMakoto HoyanoRyu KazamaSatoru WatanabeTakuya OzawaTakashi SaigawaManabu HayashiTsuyoshi YoshidaHitoshi TachikawaTakeshi KashimuraKeisuke SuzukiMasayuki NagahashiJunzo WatanabeKouji ShimadaGo HasegawaKiminori KatoHaruo HanawaMakoto KodamaYoshifusa Aizawa
著者情報
ジャーナル フリー

2004 年 68 巻 12 号 p. 1223-1226

詳細
抄録

A 53-year-old Japanese man with fulminant myocarditis was referred. Percutaneous cardiopulmonary support (PCPS) was introduced immediately and intravenous immunoglobulin (IVIG) therapy followed for 2 days. Cardiac function showed signs of recovery on the 4th hospital day and the patient was weaned from PCPS on the 7th hospital day. Creatine kinase-MB peaked at 12 h after admission and was 176 ng/ml. Endomyocardial biopsy showed active myocarditis. A marked increase of the neutralizing antibody titer suggested coxsackievirus B3 infection. Plasma concentrations of cytokines and neurohumoral factors were analyzed. Proinflammtory cytokines, such as interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF-α), and anti-inflammatory cytokines, such as IL-1 receptor antagonist, soluble TNF receptor-1 and IL-10, were elevated on admission and all had decreased on the 7th hospital day. Brain natriuretic peptide and noradrenaline were already elevated upon admission (1,940 pg/ml and 4.6 ng/ml, respectively) and decreased thereafter. Although IVIG therapy under PCPS is a common treatment for fulminant myocarditis, the immunological response in vivo remains unclear. This case demonstrated suppression of serum cytokines after IVIG and PCPS treatment. Immunological parameters in those who have been treated with IVIG and PCPS and survived without complications are of great value for evaluation of the therapy. Further analysis with more cases in a multicenter study is necessary. (Circ J 2004; 68: 1223 - 1226)

著者関連情報
© 2004 THE JAPANESE CIRCULATION SOCIETY
前の記事 次の記事
feedback
Top